Marksans Pharma informs about details of loss of certificate

08 Apr 2024 Evaluate
Marksans Pharma has informed that the Company has received intimation from Registrar and Transfer Agent, Bigshare Services on April 08, 2024 regarding the duplicate share certificates of the Company that have been issued, the details of which are enclosed. Name of Shareholder: Yogesh Anand; Folio Y001026. Pursuant to the SEBI Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated January 25, 2022 a letter of confirmation will be issued to the securities holder / claimant upon completion of necessary procedures regarding duplicate share certificates.

The above information is a part of company’s filings submitted to BSE.

Marksans Pharma Share Price

308.55 -0.45 (-0.15%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.